Searched for
ERIBULIN
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 28%Here are three golden rules investors should always follow, but there are times when they become even more important. First: Be selective i...24 Nov, 2025, 11.27 PM IST- Glenmark launches generic cancer treatment drug in USGlenmark Pharmaceuticals on Tuesday launched Eribulin Mesylate Injection, a generic cancer treatment, in the US through its subsidiary Glen...02 Sep, 2025, 02.05 PM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAre valuations in the mid-cap segment now fairly priced? No. Does it mean you should avoid the segment altogether? The answer is again no. ...09 Jul, 2025, 10.15 PM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe street is witnessing an element of profit-booking. Not surprising, as we have seen an uptrend both in the broader market and in the Nif...02 Jul, 2025, 11.37 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 18% in 1 yearIn a super bullish market, you tend to buy stocks without looking at their fundamentals. Similarly, in a bearish market, you may end up sel...05 Apr, 2025, 05.27 AM IST
- These mid-cap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsWhether it is India or across the globe, the one thing that stock markets hate (or is it fear?) the most is “uncertainty”. In the last thre...03 Apr, 2025, 05.55 AM IST
- Stock picks of the week: 5 stocks with consistent score improvement and an upside potential of up to 44%This week, the markets will react to what happens after the April 2 reciprocal tariff announcement by the Trump administration. So there is...31 Mar, 2025, 05.12 PM IST
- Looking at mid-caps? Keep your portfolio healthy: 5 mid-cap pharma stocks with an upside potential of up to 38%Even as the bears are running wild on the street causing across-the-board damage, there are sectors that have kept them at bay. And that’s ...24 Feb, 2025, 06.10 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 31%Look at how the street has treated some of the IPOs that were listed last week. It is a clear indication that there is a good amount of mon...28 Dec, 2024, 05.00 AM IST
- Stay bullish but tactical & selective on all counts: 8 large-cap stocks from different sectors with upside potential of up to 33%There are certain sectors which have a strong relationship with the stage of growth of the economic cycle – or, to put it another way, the ...19 Dec, 2024, 06.27 AM IST
- Gland Pharma shares fall 6% as ex-promoter likely sells stake in block dealsShares of Gland Pharma dropped 6% to Rs 1,745 on BSE as entities related to ex-promoter Dr Ravi Penmetsa sold 5.5% equity. Large block deal...09 Apr, 2024, 10.27 AM IST
- Gland Pharma gets USFDA nod for generic breast cancer drugGland Pharma has received approval from the USFDA to market a generic medication for breast cancer treatment, Eribulin Mesylate Injection. ...08 Apr, 2024, 05.01 PM IST
- Stocks in news: Nestle India, Titan, Vodafone Idea, Wipro, Tata SteelThe Board of Nestle India approved paying a royalty fee to its parent company Nestle S.A. The payment will be made at a rate of up to 5.25%...08 Apr, 2024, 07.03 AM IST
- Emcure to launch generic breast cancer medicineEribulin, sold by Japanese drug maker Eisai under brand name Halaven, is used to treat HER 2 negative patients. It costs Rs 5,000 per vial.03 Apr, 2019, 11.48 PM IST
- Hyderabad scientist elected as fellow of INSAThe recognition has been accorded for his contribution in the area of organic chemistry for the last two decades, according to CSIR-IICT.24 Oct, 2014, 05.01 PM IST
- Japan's Eisai to launch breast cancer drug in IndiaJapan's Eisai Pharma is slated to launch in India its novel anti-cancer drug Eribulin, sold under the brand name of Halaven.06 Nov, 2013, 03.15 AM IST
Load More
